Ohio Ozempic Lawsuit Attorneys | Kisling, Nestico & Redick

En esta página

Considering an Ozempic Lawsuit?

Certain health risks and illnesses have been linked to popular weight loss drugs still on the market.

Ozempic and Wegovy, labeled as glucagon-like peptide-1 receptor agonists, are gaining in popularity for weight loss management. They are part of a larger GLP-1 drug family that also includes Rybelsus, Mounjaro, Trulicity, and Saxenda. These medications have come under scrutiny by the Food and Drug Administration (FDA) after the administration reported several complaints through its FDA Adverse Event Reporting System in 2022.

Users have reported lasting issues of gastroparesis, ileus, gallbladder diseases, vision loss, and more. Hundreds of these cases are now consolidated in a federal multidistrict litigation (MDL) rather than a class action, so an injured patient keeps an individual claim while sharing pretrial proceedings with others. The first widely reported lawsuit against drug manufacturers Novo Nordisk and Eli Lilly & Co. was filed in August 2023, with the plaintiff alleging the defendants neglected to inform doctors of possible side effects.

If you or a loved one were diagnosed with gastroparesis, cyclic vomiting syndrome, gallbladder diseases, ileus, vision loss, or death caused by the above injuries after taking Ozempic or a similar GLP-1 medication, you may have a right to financial compensation through a dangerous drug injury claim. Contact Kisling, Nestico & Redick today. We will explain your options for compensation of your medical bills, pain and suffering, lost wages, and more.

Ozempic’s Intended Use

Ozempic and other GLP-1 drugs were intended to help people with Type 2 diabetes. The FDA approved the use of Wegovy for chronic weight management in 2021. New concerns have arisen about potential side effects.

Ozempic and Wegovy are semaglutide products. They mimic a naturally produced hormone called “glucagon-like peptide-1” or GLP-1. This hormone causes the pancreas to release insulin and block the liver from releasing sugar.

Semaglutide products help regulate insulin, keeping food in the stomach longer than usual. This sustains the feeling of a full stomach for a longer period. Higher doses interact with the brain to reduce appetite and signal a feeling of fullness. If you developed serious complications after using one of these diabetes drug injury medications, you may have grounds for a claim.

Un día soleado en Ohio, con coches circulando por una autopista que serpentea hacia el perfil urbano de una ciudad, con edificios altos, frondosos árboles verdes y un cielo azul salpicado de nubes blancas.

Somos abogados galardonados y altamente cualificados

Una insignia con el texto «Best Law Firms, Ranked by Best Lawyers, Estados Unidos, 2026» en letras negras, rojas y grises sobre un fondo con forma de escudo.
Una insignia dorada y roja con el texto «Trucking Top 10 Trial Lawyers» y una imagen de la Dama de la Justicia sosteniendo una balanza en el centro.
Logotipo blanco de «The National Trial Lawyers», en el que aparece una figura de pie sosteniendo una balanza, con el texto «The National Trial Lawyers» y «Top 100 Trial Lawyers» debajo.
Un logotipo circular con una balanza de la justicia dorada en el centro, rodeada por un borde rojo con el texto en blanco «Multi-Million Dollar Advocates Forum».
Emblema en forma de escudo dorado y negro con la balanza de la justicia, en el que se lee «Los diez mejores abogados especializados en lesiones personales de NAOPIA a nivel nacional» sobre una cinta dorada con estrellas decorativas en la parte inferior.
Logotipo circular en dorado y gris de la Asociación Americana de Abogados Litigantes (ATLA), en el que aparece la silueta de la Justicia sosteniendo una balanza, con las letras «ATLA» en blanco y en grande en el centro.
Hexágono rojo con las letras AV en blanco y grandes en el centro. Debajo se lee, en letras blancas tenues, «PREEMINENT», pero el texto más pequeño que aparece a continuación está borroso y resulta difícil de leer.
En un fondo gris claro se lee «Super Lawyers» en letras grandes y en negrita.
Un logotipo circular con un borde dorado en el que aparece, en el centro, la imagen de la Dama de la Justicia sosteniendo una balanza y una espada, rodeada de franjas azules con la inscripción «The National Trial Lawyers».
Logotipo circular con una balanza de la justicia dorada en el centro sobre un fondo rojo. El anillo exterior negro contiene las palabras «Million Dollar Advocates Forum» en blanco, todas en mayúsculas.

Ozempic’s Potential Side Effects & Risks

In March 2022, a warning about gallbladder disease was added to Ozempic’s label. In September 2023, the FDA added a new warning to Ozempic’s label about the risk of ileus.

Research has linked GLP-1 agonists like Ozempic or Wegovy to increased risk of gastroparesis, cyclic vomiting syndrome, gallbladder diseases, and ileus.

Gastroparesis

Also known as stomach paralysis, gastroparesis is a disorder that slows or stops the movement of food from your stomach to your small intestine. This can happen even when there isn’t a blockage. Symptoms include nausea, vomiting, and feeling full after starting a meal and long after finishing a meal.

GLP-1 users often report experiencing gastroparesis symptoms even after they stop taking the medication.

Cyclic Vomiting Syndrome

CVS is a disorder that causes repeated episodes of being sick and feeling sick. People with CVS typically vomit repeatedly or feel nausea often. Symptoms include nauseous feelings and extended periods of vomiting; these could be hours or even days of vomiting. Someone with CVS will go through four distinct phases: feeling ill, vomiting, recovering, and then feeling well.

Gallbladder Diseases

Some Ozempic users have reported gallbladder issues since taking the GLP-1 medication before March 2022. The afflictions vary, but some users reported cases of cancer, gallstones, or inflammation. Your gallbladder is a small organ on the right side of your body. It’s located just below your liver. It holds your body’s bile, a digestive fluid released into your small intestine.

Gallstones

Gallstones are hardened deposits of bile that can form in the gallbladder. They can range in size and number. They can cause a blockage. Symptoms include sudden and intense pain in the upper right or center of your abdomen, pain between your shoulder blades, or nausea and vomiting. Severe cases may require the removal of your gallbladder.

Cholecystitis

Also called gallbladder inflammation, cholecystitis is a redness or swelling of the gallbladder. It happens after bile becomes trapped in the organ. It can be sudden or long-term. Symptoms include intense pain in your abdomen, nausea, vomiting, fever, jaundice, runny bowel movements, or belly bloating.

Ileus

A digestive disorder, ileus acts like a blockage, preventing the passage of food, fluids, digestive secretions, and gas through the intestines. There aren’t any actual blockages. Symptoms include abdominal bloating, pain, nausea, vomiting, severe constipation, loss of appetite, and cramps.

Vision Loss (NAION)

Non-arteritic anterior ischemic optic neuropathy, or NAION, is a condition that reduces blood flow to the optic nerve and can cause sudden, painless vision loss in one eye. Researchers have reported a possible association between semaglutide use and NAION, and it has become a recognized injury in the GLP-1 litigation. Because the resulting vision loss is often permanent, NAION claims are being handled in their own federal track separate from the gastrointestinal cases. If you experienced sudden vision changes or loss after starting Ozempic or another GLP-1 drug, you should be evaluated by a doctor and may have grounds for a claim.

Intraoperative Pulmonary Aspiration

Taking these medications has been known to increase the risk of anesthesia-related aspiration, which makes any thoracic surgery more dangerous to complete.

Mental Health Side Effects

The FDA is monitoring reports that those who took Ozempic experienced an increased risk of thoughts of self-harm and suicidal thoughts. Several users have reported feeling overwhelmed and anxious and an increase in mental health problems since taking the drug.

Possible Ozempic Compensation

No two cases are the same, but you deserve the chance to recover financially from your losses.

Your potential recovery from a legal claim or lawsuit connected to an Ozempic-related gastroparesis, CVS, gallbladder disease, vision loss, or death may include your past & future medical expenses, lost income, pain & suffering, mental anguish, punitive damages, and wrongful death damages.

Medical Expenses

You or a loved one may be taking Ozempic and other GLP-1 drugs for an existing medical condition. It’s possible that you may be suffering from adverse side effects even if you stop taking the medication. You could pursue compensation for costs associated with your medical care. That includes your current and future medical expenses the medication has caused.

That may include the expense of monitoring your condition or treating it. Some cases required gastric bypass surgery to achieve some relief.

Lost Income

Some Ozempic users have reported they have missed work because of their condition after taking the GLP-1 medication. Cycles of constant vomiting interfered with their ability to work. If you are experiencing similar issues, you may be eligible for compensation.

Pain & Suffering

Users experiencing adverse side effects of Ozempic and GLP-1 treatments have reported extreme physical pain and mental suffering. If you are experiencing mental anguish after taking Ozempic, you may be able to pursue compensation. Talking to an experienced drug lawsuit attorney at KNR can help you calculate your losses accurately.

Indemnización punitiva

In cases of extreme negligence, a court may award a plaintiff punitive damages. These apply in certain cases. These damages are not intended to compensate you but to punish the defendant for their negligent or reckless actions. In this case, drug manufacturers Novo Nordisk and Eli Lilly and Co. have been named in current lawsuits.

Reclamaciones por muerte por negligencia

In instances when Ozempic’s side effects can be linked to someone’s death, their surviving family may be able to pursue a wrongful death claim. These claims can hold a liable party responsible for their negligent actions that led to a loved one’s death. Talk to our Ohio wrongful death attorneys to discuss your case’s legitimacy.

Not sure whether your injuries qualify? Call KNR at 1-800-HURT-NOW for a free, no-obligation case evaluation, and we will review what happened and explain your options.

Ohio Ozempic Lawsuit Deadlines and Filing

If you live in Ohio, strict deadlines apply, and most claims are filed into the federal GLP-1 litigation rather than a class action.

Ohio sets a time limit, called a statute of limitations, on how long you have to bring a product-liability or personal-injury claim. Under Ohio Revised Code 2305.10, most bodily-injury claims, including those involving a defective or dangerous drug, must generally be filed within two years of when the injury was discovered or reasonably should have been discovered. If a loved one died from a GLP-1 related injury, Ohio Revised Code 2125.02 generally gives the family two years from the date of death to bring a wrongful death claim.

When an injured Ohioan brings a GLP-1 claim today, it is typically filed in or transferred into the federal multidistrict litigation rather than pursued as a class action. In an MDL, your case stays an individual lawsuit with its own facts and damages, but it is coordinated with thousands of similar cases for efficient pretrial handling. Because these deadlines can be complicated and fact-specific, it is best to speak with an attorney promptly so you do not lose your right to file.

Ozempic Lawsuit Status and Timeline

2026: Cases Continue to Grow in the GLP-1 MDL

As of June 1, 2026, roughly 3,763 cases were pending in MDL No. 3094, the consolidated federal GLP-1 gastrointestinal-injury litigation in the Eastern District of Pennsylvania before Judge Karen S. Marston. New cases continue to be filed each month as more patients come forward. No global settlement has been reached.

December 2025: Separate MDL Created for Vision Loss

The Judicial Panel on Multidistrict Litigation created a separate proceeding, MDL No. 3163, for GLP-1 NAION vision-loss claims, centralized in the Eastern District of Pennsylvania and also assigned to Judge Marston. The panel kept the vision-loss cases on their own docket rather than folding them into the gastrointestinal MDL.

August 2025: Motion to Dismiss Largely Denied

On August 15, 2025, Judge Marston largely denied the drugmakers’ motion to dismiss the master complaint, allowing the plaintiffs’ key failure-to-warn and related claims to move forward in the gastrointestinal-injury MDL.

February 2024: GLP-1 Cases Consolidated as MDL No. 3094

The Judicial Panel on Multidistrict Litigation consolidated the federal Ozempic and GLP-1 gastrointestinal-injury lawsuits into MDL No. 3094, In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, in the Eastern District of Pennsylvania. A master complaint followed as the cases were coordinated for pretrial proceedings.

January 2024: FDA Evaluating Additional Reports

The FDA announced it had started evaluating reports of hair loss, suicidal thoughts, and aspiration under sedation and anesthesia among Ozempic and other GLP-1 users. Several reports were made to the FDA’s Adverse Event Reporting System database.

December 2023: Early Dismissal Motion Addressed

A judge overseeing an early claim against drug manufacturer Novo Nordisk denied much of the company’s dismissal motion while dismissing certain express warranty claims. Plaintiff lawyers filed a motion to consolidate Ozempic cases as the litigation grew.

August 2023: One of the Earliest Gastroparesis Lawsuits Filed

One of the earliest Ozempic and Mounjaro gastroparesis lawsuits was filed by Jaclyn Bjorklund. Summonses were issued to Novo Nordisk and Eli Lilly and Co. on August 3.

August 2022: Early Gallbladder Claims Begin

Lawyers began accepting Ozempic gallbladder lawsuits after a research letter was published linking increased risk of gallbladder disease and gallstones to Ozempic use. Separately, judges centralized patent-infringement lawsuits by Novo Nordisk against generic drug makers into multidistrict litigation in Delaware.

Ozempic Lawsuit FAQ

Do I qualify for an Ozempic lawsuit in Ohio?

You may qualify if you took Ozempic or another GLP-1 drug, such as Wegovy, Rybelsus, Mounjaro, Trulicity, or Saxenda, and were later diagnosed with a serious injury like gastroparesis, ileus, gallbladder disease, or NAION vision loss. Eligibility depends on your medical records, how long you used the drug, and when you were diagnosed. The best way to know is to have an attorney review your situation at no cost.

Is the Ozempic lawsuit a class action or an MDL?

The federal Ozempic and GLP-1 cases are organized as multidistrict litigation, not a class action. In an MDL, your lawsuit remains your own individual case with its own facts and damages, but it is grouped with similar cases for coordinated pretrial proceedings. The gastrointestinal-injury cases sit in MDL No. 3094, and the NAION vision-loss cases are in a separate MDL.

How long do I have to file an Ozempic lawsuit in Ohio?

Ohio generally gives you two years to file a personal-injury claim under Ohio Revised Code 2305.10, and two years to file a wrongful death claim under Ohio Revised Code 2125.02. The clock can start when the injury is discovered, which makes these deadlines fact-specific. To protect your rights, it is important to talk with an attorney as soon as possible.

Has there been an Ozempic settlement yet?

No global Ozempic or GLP-1 settlement has been reached. The litigation is still moving through pretrial proceedings in federal court, and the number of pending cases continues to grow. Any figures you may see described online as potential settlement values are estimates from commentators, not court-ordered awards.

What injuries qualify for an Ozempic or GLP-1 lawsuit?

Injuries commonly raised in GLP-1 lawsuits include gastroparesis (stomach paralysis), cyclic vomiting syndrome, ileus and bowel obstruction, gallbladder disease, and NAION vision loss. Wrongful death claims may apply when one of these injuries contributed to a death. An attorney can tell you whether your specific diagnosis fits the current litigation.

Call KNR’s Ozempic Attorneys

If you or a loved one took Ozempic or another GLP-1 medication before you developed gastroparesis, vision loss, or another serious injury, let KNR assess your damages and eligibility for compensation. As experienced Ohio mass tort and class action lawyers, we can help secure what you are entitled to without risk or up-front cost. We also handle related claims, including Paraquat lawsuit claims and Elmiron lawsuit claims.

Contact us today at 1-800-HURT-NOW to schedule a free case evaluation.

Cinco personas vestidas de forma profesional están sentadas alrededor de una mesa de reuniones, utilizando ordenadores portátiles y revisando documentos. Al fondo se ven grandes ventanales y vegetación, lo que sugiere un entorno de oficina moderno.

¿Qué hace que KNR sea especial?

Llevamos más de 20 años prestando servicio en Ohio

Desde nuestra fundación en 2005, Kisling, Nestico & Redick se ha dedicado a ayudar a las víctimas de lesiones personales a luchar por la indemnización que se merecen cuando un accidente afecta a su estilo de vida. Hemos ayudado a más de 10 000 personas y estamos dispuestos a seguir luchando por los habitantes de Ohio y por cualquier persona que merezca una indemnización por sus reclamaciones por lesiones personales.

Consultas gratuitas // Disponibles las 24 horas del día, los 7 días de la semana // Si no ganamos, no cobramos

Ponte en contacto con KNR

Ponte en contacto con KNR ahora mismo para iniciar tu caso

Nombre(Obligatorio)

**El hecho de enviar una descripción de su caso o participar en un chat no establece una relación abogado-cliente. No obstante, todo lo que nos comunique será confidencial, incluso si no se convierte en cliente de KNR. Haga clic en el botón «Enviar» que aparece a continuación para confirmar su envío.